George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.00
Bid: 61.00
Ask: 63.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.279%)
Open: 62.00
High: 62.00
Low: 62.00
Prev. Close: 62.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Patent Case Updates

24 May 2023 07:00

RNS Number : 4235A
PCI-PAL PLC
24 May 2023
 

PCI-PAL PLC

("PCI Pal", "the Company" or "the Group")

 

Trading and Patent Case Updates

 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, is pleased to provide a trading update for the current financial year ending 30 June 2023 ("FY23"), and an update regarding the ongoing patent case with one of its competitors.

 

Trading Update

 

Since the half year, PCI Pal has achieved continued strong momentum with excellent performance across its key metrics. The Board is particularly pleased with the strength of its global sales pipeline which is driving an acceleration in new business sales in the second half of the year. New ACV for the Group year to date is now at £3.4 million, with a strong outlook to the financial year end which will help to further underpin revenue growth in FY24.

 

The strength of the Company's channel partner strategy is reflected in 86% of these new contracts having come through PCI Pal's market leading partner eco-system. Additionally of note is that £3.0 million (87%) of the new business signed is from new customers to the Group which is a pleasing 34% increase compared to the same period last year. 

 

Highlight new customer contracts won in the second half include a number of enterprise deals in the US where the Group has experienced accelerated growth of its sales pipeline throughout FY23. These wins include a major contract with a Fortune 50 healthcare provider, as well as another new enterprise contract with one of the largest electronics companies in the world. Further to the US progress, the Board is pleased to report that the Company has also signed its largest contract to date in Australia, with a well-known global insurer.

 

Patent Case Update

 

PCI Pal disrupted the secure payments market for contact centres by bringing true public cloud capabilities to the space. PCI Pal's patented cloud deployment methods have empowered light-touch, cost effective access to its products and services, which was something not seen before in a market historically burdened by legacy hardware solutions.

 

Today PCI Pal has the most mature global cloud offering in the market and has delivered the strongest growth momentum of any company in the space for a number of years. It has long been the opinion of the Board that Sycurio Limited (formerly Semafone Limited) ("Sycurio") brought its opportunistic patent infringement claim to try to disrupt PCI Pal's growth and momentum.

 

The Board continues to strongly refute these unfounded patent infringement claims.

 

Investors are referred to the Company's patent case update included in its interim report released on 14 March 2023. Since then, the parties have exchanged expert witness reports and subsequently reviewed mutual responses to these reports. The Board continues to be confident in being successful in both the Company's defence for non-infringement, as well as its counter claims of invalidity of the Sycurio patents in question.

 

The Company confirms that there have been discussions with Sycurio regarding the case. To date these discussions have not produced any sensible settlement options that the Board believes are in the best interests of the business. The Board continues to seek the best outcome for the business and is entirely prepared for trial on that basis.

 

The UK Trial is scheduled for eight days from 12 June 2023. A ruling is expected up to four months from that time.

 

Commenting, James Barham, Chief Executive Officer, said:

 

"It is exciting to see the continued progress of the Group this year, especially during times when there have been a number of economic headwinds across our main customer regions.

 

"The momentum in the US is particularly encouraging and evidences the successful execution of our strategy since launch in the region. With the majority of our global partners headquartered in the US, progress in the region also supports our sales progression globally as many of these partners have businesses across Europe, APAC, and ANZ. As a result of this momentum, the Board is confident that results for FY23 will be in line with management expectations.

 

"In terms of the patent case, whilst we will continue to consider all sensible settlement options to resolve the case, we are entirely prepared for trial. We have built a strong case and during this period of preparation our confidence has only grown for both the defence of the unfounded infringement claims, as well as our own counter claims of invalidity."

 

1ACV is the annual recurring revenue generated from a new contract.

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

finnCap (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks/Fergus Sullivan (Corporate Finance)

Sunila de Silva (Corporate Broking)

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Nick Rome

+44 (0) 797 122 1972

PCIPAL@walbrookpr.com

 

About PCI Pal:

 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKNBQKBKBDPB
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.